Market Research Logo

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat. The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
...Show More ...Show Less


Pharmaceuticals Industry Research & Market Reports

  • Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024

    ... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More

  • An Increased Focus on Tick Borne Testing

    The public is eager for a better tick-borne disease test, with Lyme disease and other tickborne diseases on the rise in the United States. Read More

  • The State of Antimicrobial Resistance

    For nearly as long as there have been antibiotics, the medical community has worried about antimicrobial resistance. Read More

  • Europe Pharmaceuticals & Healthcare Q4 2018

    ... to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue ... Read More

  • Ghana Pharmaceuticals & Healthcare Q4 2018

    ... has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a ... Read More

  • Hong Kong Pharmaceuticals & Healthcare Q4 2018

    ... cope with a rapidly ageing population. On the private side too, the government has beenpromoting the development of private hospitals as part of its reform initiatives to improve the long-term sustainability of thecountry’s healthcare system. Read More

  • Latin America Pharmaceuticals & Healthcare Q4 2018

    ... for multinational pharmaceutical firms with a risingburden of chronic diseases and increasing access to healthcare services. However, in the short-term growth opportunities in theregion's major markets will be repressed by significant political and economic risks. Read More

  • Sub-Saharan Africa Pharmaceuticals & Healthcare Q4 2018

    ... within the generic medicines sector, while the larger, moredeveloped markets present viable opportunities for patented medicine sales in urban regions. Cooperative agreements withinternational firms will provide opportunities for domestic firms to expand their manufacturing capacities. Read More

  • Middle East And North Africa Pharmaceuticals & Healthcare Q4 2018

    ... opportunities for multinational drugmakers looking to expand to emergingmarkets. Heightened industry and country risk dissuade company interest and the larger markets dominate multinational activityfor patented medicine sales. Ample opportunities exist in the generics market segment. Read More

  • Costa Rica Pharmaceuticals & Healthcare Q4 2018

    ... offers superior market access and development opportunities to multinationals based on factorssuch as continuous improvement in healthcare infrastructure and government commitment to upholding an attractive businessenvironment. Additionally, the demand for innovative medicines will still need ... Read More

  • Asia Pharmaceuticals & Healthcare Q4 2018

    ... However, these markets will no longer providesignificant revenue growth due to aggressive cost-containment. Instead, growth opportunities will be plentiful in emerging markets.We note that due to continued regulatory challenges and a growing focus on cost-efficiency, ... Read More

  • El Salvador Pharmaceuticals & Healthcare Q4 2018

    ... for pharmaceutical investment. Despite this, a steady number ofcollaborations with international organisations and businesses is improving the standard of healthcare and raising the long-termgrowth prospects of the country's low penetration of pharmaceuticals and medical equipment. Read More

  • Germany Pharmaceuticals & Healthcare Q4 2018

    ... to services, will continue tosupport this potential. However, we do caution that market access is now challenging, as authorities use a range of cost-containment measures and downward price pressures as a means of controlling state ... Read More

  • Nicaragua Pharmaceuticals & Healthcare Q4 2018

    ... pharmaceutical companies operating in thecountry. Furthermore, the ongoing political crisis and heightened social unrest will exacerbate the risks associated with Nicaragua,further deterring multinational drugmakers from investing in what is already one of the least attractive ... Read More

  • Uganda Pharmaceuticals & Healthcare Q4 2018

    ... remain dominant, while the government plans to localisedrug production to boost medicine sustainability. While the market has brighter long-term prospects, multinational drugmakerappetite will remain subdued despite the positive economic growth forecast over the coming years. Read More

  • Global Pharmaceuticals & Healthcare Q4 2018

    ... face increasingly protectionist policies in emerging markets.These policies can be divided into localisation requirements and investment incentives, including subsidies and tariffs.Multinational pharmaceutical firms must assess their market entry strategy to reflect each market's individual protectioniststance. Read More

  • Global Bipolar Disorder Therapeutic Market 2019-2023

    ... hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar I, bipolar II, and cyclothymia. This condition can be managed with a ... Read More

  • Mental Health & Substance Abuse Services

    ... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More

  • Global Human Vaccine Market 2018-2022

    ... mortality rates, and life expectancy. Technavio’s analysts forecast the Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022. Covered in this report The report covers the present scenario and ... Read More

  • Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024

    ... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More

  • Commercial Interest at ESMO Annual Meeting 2018: Analytical Tool

    ... from the European Society of Medical Oncology (ESMO 2017) congress. Similar in scope to it's American cousin ASCO, this conference features more than 2000 abstracts detailing the latest ground-breaking science and in this too we ... Read More

  • Pharmaceuticals in Australia

    ... national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market ... Read More

  • Kissei Pharmaceutical Co Ltd (4547) - Financial and Strategic SWOT Analysis Review

    ... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More

  • Sawai Pharmaceutical Co Ltd (4555) - Financial and Strategic SWOT Analysis Review

    ... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ... Read More

  • Xilinx Inc (XLNX) - Financial and Strategic SWOT Analysis Review

    ... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More

< prev 1 3 4 5 6 7 8 9 10